NCT06596083

Brief Summary

This study aims to investigate the effects of post-exercise and pre-sleep exogenous ketosis via oral ketone ester supplementation during a 5 week simulated altitude training camp.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 27, 2024

Completed
14 days until next milestone

Study Start

First participant enrolled

September 10, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
26 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2024

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

1 month

First QC Date

August 27, 2024

Last Update Submit

September 10, 2024

Conditions

Keywords

Altitude training campExerciseLive high, train lowEPO

Outcome Measures

Primary Outcomes (3)

  • Total hemoglobin mass

    Using the optimized CO-re-breathing method, total hemoglobin mass will be estimated

    Day 0, Day 35, Day 42

  • Skeletal muscle capillarization

    Changes in muscle capillarization are measured using immunohistochemical anlyses

    Day 0, Day 35, Day 42

  • Cycling exercise performance

    maximal average power output during a 30 minute time trial, cycling efficiency test and repeated sprint test

    Day 0, Day 35, Day 42

Secondary Outcomes (4)

  • Maximal oxygen uptake (VO2max)

    Day 0, Day 35, Day 42

  • Change in peripheral blood flow

    Day 0, Day 35, Day 42

  • Serum EPO concentrations

    Day 0, day1, week1, week2, week3, week4, week5, day35, day42

  • Sleep Architecture

    Day 0, day1, week 3, day35, day42

Study Arms (2)

Placebo Comparator

PLACEBO COMPARATOR

Training intervention: 5 weeks of live high, train low followed by an additional 1 week of reduced training (to simulate preparation for an upcoming event or race) Dietary intervention: placebo supplement

Dietary Supplement: Placebo supplement

Experimental group

EXPERIMENTAL

Training intervention: 5 weeks of live high, train low followed by an additional 1 week of reduced training (to simulate preparation for an upcoming event or race) Dietary intervention: Ketone ester supplement

Dietary Supplement: Ketone ester supplement

Interventions

Placebo supplementDIETARY_SUPPLEMENT

oral supplement containing: 16.4 grams of medium chained triglycerides, 1mM or sucrose octaacetate and water

Placebo Comparator
Ketone ester supplementDIETARY_SUPPLEMENT

Oral supplement containing: 25 grams of pure (R)-3-hydroxybutyl-(R)-3-hydroxybutyrate ketone monoester drink

Experimental group

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Physically fit and regularly involved in physical activity (2-5h per week)
  • Good health status confirmed by a medical screening
  • Non-smoking

You may not qualify if:

  • Any kind of injury/pathology that is a contra-indication to perform high-intensity exercise
  • Any kind of injury/pathology that is a contra-indication for exposure to hypoxia
  • Ongoing pregnancy or breastfeeding
  • intake of any medication or nutritional supplement that is proven to affect exercise performance during the last month prior to the start of the study
  • Involvement in elite athletic training at a semi-professional or professional level
  • Exposure to altitudes higher than 1500 m during the 3 months prior to the start of the study
  • Blood ferritin levels below 30 ng/mL
  • Current participation in another research trial
  • Any other argument to believe that the subject is unlikely to succesfully complete the full study protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KU Leuven

Leuven, Vlaams-Brabant, 3000, Belgium

RECRUITING

MeSH Terms

Conditions

HypoxiaMotor Activity

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Chiel Poffé

    KU Leuven

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Participants and investigators are blinded from the experimental condition (KE or CON). Supplements are provided in non transparent tubes and the control supplement is identical in taste and viscosity to the ketone supplement.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Participants will go through the entire 5 week training camp and 1 week follow up while taking either ketone ester supplements (KE) or an isocaloric placebo (CON).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
postdoctoral researcher

Study Record Dates

First Submitted

August 27, 2024

First Posted

September 19, 2024

Study Start

September 10, 2024

Primary Completion

October 15, 2024

Study Completion

October 15, 2024

Last Updated

September 19, 2024

Record last verified: 2024-09

Locations